SCHEMBL7203542

SCHEMBL7203542

CN(C(=O)Oc1ccc(Cl)cc1)C1CCC(CCCOS(C)(=O)=O)CC1

nearest known ligand 0.61

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
LSS P48449 11/20 0.61
ACHE P22303 2/20 0.36
GPR119 Q8TDV5 1/20 0.35
BCL2A1 Q16548 1/20 0.35
LMNA P02545 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
MAPT P10636 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7207247 0.96 LSS (0.64) LSSACHEGPR119
SCHEMBL27578319 0.87 LSS (0.59) LSSGPR119LMNA
SCHEMBL6019087 0.87 LSS (0.48) LSSACHEGPR119LMNAL3MBTL1
SCHEMBL6019091 0.87 LSS (0.48) LSSACHEGPR119LMNAL3MBTL1
SCHEMBL6020056 0.87 LSS (0.57) LSSACHEGPR119LMNAL3MBTL1
SCHEMBL6020052 0.87 LSS (0.57) LSSACHEGPR119LMNAL3MBTL1
SCHEMBL6019198 0.85 LSS (0.48) LSSACHEGPR119LMNAL3MBTL1
SCHEMBL6019193 0.85 LSS (0.48) LSSACHEGPR119LMNAL3MBTL1
SCHEMBL4804067 0.83 LSS (0.69) LSSACHELMNAL3MBTL1
SCHEMBL4804058 0.83 LSS (0.69) LSSACHELMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100455566-C Novel derivatives of aminocyclohexane HOFFMANN LA ROCHE (CH) 2009-01-28 CN disclosed
CN-1468214-A Novel derivatives of aminocyclohexane - 2004-01-14 CN disclosed
EP-1311475-A1 NOVEL AMINOCYCLOHEXANE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2003-05-21 EP disclosed
WO-2002014267-A1 NOVEL AMINOCYCLOHEXANE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2002-02-21 WO disclosed